Philippe Pinton

Dr. Philippe Pinton

Health & Life Sciences, Shiroito Co. Ltd., Tokyo, Japan
orcid

Biography

Dr. Philippe Pinton is an international physician‑scientist and executive leader with over 25 years of experience across global research and development, medical affairs, and organizational transformation in the pharmaceutical and biotechnology industries. He has held senior roles in Europe, Asia, and the United States, including serving as Senior Vice President and Head of Global Research & Medical at Ferring Pharmaceuticals, where he led a 375‑person, multi‑continental organization spanning Discovery, Translational Sciences, Clinical Development, Biomarkers, Computational Sciences, and Medical Excellence. He is currently Chief Executive Officer and Co‑Founder of Shiroito Co., Ltd., a Tokyo‑based company focused on AI‑native health architectures, clinical strategy, and innovation. His work integrates real‑world evidence, EMR‑linked clinical depth, and regulatory‑aligned analytics to advance precision therapeutics, oncology, rare‑disease policy, and next‑generation clinical modeling in Japan. Dr. Pinton has contributed to more than 35 INDs/NDAs and over 50 product launches in major companies including Eli Lilly, Novartis, Takeda, and Ferring. His scientific leadership spans immunology, gastroenterology, reproductive medicine, urology, oncology, and the microbiome, with pioneering contributions in AI, machine learning, multi‑omics integration, digital twins, and in silico clinical studies.

Affiliations

Shiroito Co. Ltd.

Tokyo, Japan

Health & Life Sciences

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.